In summary, by both MCA analysis and classical statistical tests we could demonstrate that, in breast cancer, high SQLE GE characterizes clinically aggressive tumors (higher grade, larger size, and positive nodal status ones), and that SQLE tends to be overexpressed in Her2 + and ER- cases. The gene discussed is ERBB2; the disease is breast cancer.